The Generic Animal Drug Alliance ("GADA" or "the Alliance") is an independent, professional trade association serving those organizations with interests in generic animal drug products. GADA represents members’ interests before federal regulatory agencies and Congress.
The Alliance was initially formed following enactment of the Generic Animal Drug and Patent Term Restoration Act of 1988, and was originally affiliated with the Generic Pharmaceutical Industry Association (GPIA), before organizing separately as the Animal Drug Alliance. After several years as the Animal Drug Alliance, the organization was renamed as the Generic Animal Drug Alliance in order to more clearly state its primary objective:
“To provide assistance to organizations, consultants and other entities engaged or interested in the manufacture and sale of generic animal health products and active pharmaceutical ingredients.”
GADA represents the majority of companies with JINADs filed with CVM and with approved and/or pending ANADAs. Among its sponsor Members, more than 85% are actively engaged in the development of ANADAs.
GADA is the only trade association that represents the interests of generic animal health companies in the United States.